---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-030540"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:43:18.435659+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma enters $150K AUD loan agreement with 12% interest, due Nov 2024

## Summary
- Loan of $150,000 AUD effective Aug 1, 2024, with maturity Nov 1, 2024.
- Interest rate 12% per annum; prepayable at any time without penalty.
- Proceeds will be used for general working capital purposes.
- Loan issued under private placement exemption per Section 4(a)(2) and Rule 506.

## SEC filing metadata
- accession: 0001493152-24-030540
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315224030540/0001493152-24-030540-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315224030540/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-030540
- JSON: https://secwatch.observer/filing/0001493152-24-030540.json
- Plain text: https://secwatch.observer/filing/0001493152-24-030540.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.